Detecting liver fibrosis with Gd-EOB-DTPA-enhanced MRI: A confirmatory study

Related Experiment Video

Updated: Feb 11, 2026

Investigations on the GaIII Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue
11:22

Investigations on the GaIII Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue

Published on: August 17, 2016

10.5K

Niklas Verloh1, Kirsten Utpatel2, Michael Haimerl3

  • 1Department of Radiology, University Hospital Regensburg, Regensburg, Germany. niklas.verloh@ukr.de.

Scientific Reports
|April 20, 2018
PubMed

Insights

Gadolinium-EOB-DTPA enhanced MRI can accurately assess liver fibrosis and cirrhosis. This non-invasive method shows strong correlations between contrast uptake and disease grade, aiding clinical diagnosis.

Area of Science:

  • Radiology
  • Hepatology
  • Medical Imaging

Background:

  • Liver fibrosis and cirrhosis are significant health concerns.
  • Accurate staging of liver disease is crucial for patient management.
  • Current diagnostic methods can be invasive.

Purpose of the Study:

  • To prospectively validate the use of Gd-EOB-DTPA enhanced liver MRI for assessing fibrosis and cirrhosis.
  • To confirm correlations between contrast enhancement and Ishak scores.
  • To establish MRI as a non-invasive diagnostic tool.

Main Methods:

  • Prospective study of patients undergoing liver surgery.
  • Gd-EOB-DTPA enhanced 3 Tesla MRI was performed.
  • Correlation analysis between liver parenchyma relative enhancement (RE) and Ishak fibrosis/cirrhosis scores.

Main Results:

  • Established cut-off values for RE correlating with Ishak scores (e.g., Ishak ≥ 4, RE-cut-off 0.60).
  • Gd-EOB-DTPA enhanced MRI demonstrated high sensitivity (≥86%) and positive predictive value (≥86%).
  • Strong correlations were confirmed between RE and fibrosis/cirrhosis grades.

Conclusions:

  • Gd-EOB-DTPA enhanced liver MRI is a reliable non-invasive method for grading liver fibrosis and cirrhosis.
  • The findings support the clinical utility of this imaging technique.
  • MRI offers a valuable alternative to invasive liver biopsy for disease assessment.

More Related Videos

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat09:27

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat

Published on: June 17, 2016

12.6K
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

3.3K

Related Concept Videos

Imaging Studies I: CT and MRI01:14

Imaging Studies I: CT and MRI

Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
921
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
895
Self-Evaluation: Self-Enhancement and Self-Verification03:00

Self-Evaluation: Self-Enhancement and Self-Verification

Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
5.8K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
549
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
273
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
213